Coinbase, Circle Stocks Slide as Bank Group Sues OCC Over Crypto Charters 
Airbus Spain Workers Approve Deal to End Months of Strikes 
DogeOS Launches Testnet to Bring DeFi Apps to Dogecoin 
Citi Raises Bitcoin Target to $113,000 as Crypto Outlook Improves 
Flydubai Co-Pilot Tried to Crash Israel-Bound Jet, Netanyahu Says 
Lynas Shares Slide on A$968 Million Meteoric Resources Deal 
Chainalysis AI Traces $387M Bitget Hack in Under 10 Minutes 
XRP Ledger Hits 10 Million AI Payments as Bitcoin Retreats 
Volvo Cars Drops Full-Year Outlook as China, US Sales Weaken 
Italgas to Buy 22.5% Stake in Portugal’s Floene for €120 Million 
Trump Praises Boeing 737 Max After Flydubai Crash Attempt 
California AG Subpoenas OpenAI Over AI Cybersecurity Incidents 
Robinhood Stock Nears $114 as Jobs Data Boosts Risk Appetite 
Zcash Awards $8 Million in Grants After Orchard Bug Crisis 
Goldman Sachs Names CATL, Zenergy Top China Battery Picks 
Bank of America Sees EUR/USD at 1.15 by Year-End 
Add as a preferred source on Google
NEW YORK, March 28, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Colorado on behalf of investors who purchased DaVita Inc. (NYSE:DVA) securities between August 5, 2015 and October 21, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/davita-inc. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DaVita and its senior executives purposefully steered patients into needless insurance plans to maximize profits; (2) DaVita was using American Kidney Fund to facilitate these inappropriate practices; (3) therefore DaVita’s revenues and profits were illegally acquired; (4) as a result, DaVita lacked effective internal controls over financial reporting.
On January 6, 2017, the Wall Street Journal published an article revealing that DaVita had received subpoenas from federal prosecutors seeking “the production of information related to charitable premium assistance” in connection with DaVita’s ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis.
If you suffered a loss in DaVita you have until April 3, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/davita-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
